Medical/Pharmaceuticals

SP Manufacturing expands into the United States

New Design and Development Center in California provides advanced engineering and development services for SP Manufacturing's global customers.  SAN DIEGO, Calif., Nov. 8, 2023 /PRNewswire/ -- SP Manufacturing, a leader in electronic manufacturing services for mission-critical industries, announc...

2023-11-08 10:00 1889

Docquity Expands Digitized Patient Access Programs To Enhance Healthcare Outcomes in Thailand

* After a successful pilot in the Philippines, five DocquityCare Patient Access Programs (PAPs)have been launched in Thailand * DocquityCare PAP will support more than 100 hospitals and 250 healthcare professionals (HCPs) to improve patient care for those with cancer and other life-threatenin...

2023-11-08 10:00 2347

Antengene to Host 2023 R&D Day and Discuss Key Data with KOLs

* During the event, Antengene will review promising data of its R&D pipeline, includingATG-031 (anti-CD24 monoclonal antibody), ATG-101 (PD-L1/4-1BB bispecific antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), ATG-037 (CD73 inhibitor), and ATG-008 (dual mTORC1/2 inhibitor). * The vir...

2023-11-08 08:30 1903

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

* ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations, representing the first innovation in endocrine therapy in nearly 20 years. * ESR1 mutations are present in up to 40% of ER+, HER2- advance...

2023-11-08 02:01 1765

Discovery Life Sciences Announces New CEO

Greg Herrema to Spearhead Next Phase of Global Biospecimen and Biomarker Company's Expansion HUNTSVILLE, Ala., Nov. 7, 2023 /PRNewswire/ -- Discovery Life Sciences, the Biospecimen and Biomarker Specialists, announced today the appointment ofGreg Herrema as its new chief executive officer. A lea...

2023-11-07 23:01 2078

Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, With No Distribution to Other Organs

* Company's eTurna™ delivery platform ensures unprecedented precision, safety * In-vivo biodistribution of mRNA into dermal cells, tissues shows high transfection efficiency, gene expression * Data presented at ASDS Annual Meeting MOUNTAIN VIEW, Calif., Nov. 7, 2023 /PRNewswire/ -- Turn Biot...

2023-11-07 21:30 2724

Registration for the 7th IFPA Conference 2024 now open

STOCKHOLM, Nov. 7, 2023 /PRNewswire/ -- IFPA (International Federation of Psoriasis Associations) is thrilled to announce the 7th IFPA Conference (former World Psoriasis & Psoriatic Arthritis Conference), set to take place fromJune 27 to 29, 2024, in the vibrant city of Stockholm, Sweden. Establi...

2023-11-07 18:00 2016

Antech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory

Antech to offer UK veterinary professionals a complete and flexible diagnostics portfolio spanning reference labs, in-house diagnostics, imaging and software WARWICK, England, 7 Nov. 2023 /PRNewswire/ -- Antech, the full-service veterinary diagnostics business that is part of the Science & Diagno...

2023-11-07 15:30 1829

KN026 was Granted Breakthrough Therapy Designation by CDE

SUZHOU, China, Nov. 7, 2023 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced, that the Center for Drug Evaluation (CDE) ofChina's National Medical Products Administration (NMPA) granted a Breakthrough Therapy d...

2023-11-07 08:51 1735

Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia

* A survey conducted in seven Asian markets, including Singapore, revealed that respondents, on average, spent 6.8 years on their fertility journey, with 3.6 years dedicated to trying to conceive naturally.1,2 * In Indonesia, Japan, Korea, Singapore, and Vietnam, at least 70 percent of respon...

2023-11-07 08:15 1167

Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia

* A survey conducted in seven Asian markets, including Taiwan, revealed that respondents, on average, spent 6.8 years on their fertility journey, with 3.6 years dedicated to trying to conceive naturally.1,2 * In Indonesia, Japan, Korea, Singapore, and Vietnam, at least 70 percent of responden...

2023-11-07 08:15 1220

Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia

* A survey conducted in seven Asian markets, including Japan, revealed that respondents, on average, spent 6.8 years on their fertility journey, with 3.6 years dedicated to trying to conceive naturally.1,2 * In Indonesia, Japan, Korea, Singapore, and Vietnam, at least 70 percent of respondent...

2023-11-07 08:15 1266

Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia

* A survey conducted in seven Asian markets, including Indonesia, revealed that respondents, on average, spent 6.8 years on their fertility journey, with 3.6 years dedicated to trying to conceive naturally.1,2 * In Indonesia, Japan, Korea, Singapore, and Vietnam, at least 70 percent of respon...

2023-11-07 08:15 1201

Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia

* A survey conducted in seven Asian markets, including South Korea, revealed that respondents, on average, spent 6.8 years on their fertility journey, with 3.6 years dedicated to trying to conceive naturally.1,2 * In Indonesia, Japan, South Korea, Singapore, and Vietnam, at least 70 percent o...

2023-11-07 08:15 1387

Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia

* A survey conducted in seven Asian markets, including India, revealed that respondents, on average, spent 6.8 years on their fertility journey, with 3.6 years dedicated to trying to conceive naturally.1,2 * In Indonesia, Japan, Korea, Singapore, and Vietnam, at least 70 percent of respondent...

2023-11-07 08:15 1088

Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia

* A survey conducted in seven Asian markets, including Vietnam, revealed that respondents, on average, spent 6.8 years on their fertility journey, with 3.6 years dedicated to trying to conceive naturally.1,2 * In Indonesia, Japan, Korea, Singapore, and Vietnam, at least 70 percent of responde...

2023-11-07 08:15 1322

Clover Completes BLA Submission for Seasonal Influenza Vaccine in Brazil

-- Clover's seasonal influenza vaccine BLA submission has been completed in Brazil, boosting Clover's global presence --  SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.  (Clover; HKEX: 02197), a global commercial-stage biotechnology compa...

2023-11-07 08:00 1764

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

REYKJAVIK, Iceland, Nov. 6, 2023 /PRNewswire/ -- A comprehensive new study from deCODE genetics, a subsidiary of Amgen, published today in Nature Genetics, provides insights into the epidemiology and somatic and germline genetics of clonal hematopoiesis. Whole genome sequence data fromIceland and...

2023-11-07 00:00 3146

Phase I Study Results for Qilu Pharmaceutical's Iparomlimab (QL1604) Now Published

JINAN, China, Nov. 6, 2023 /PRNewswire/ -- Recently, the results of the Phase I study for iparomlimab (R&D code: QL1604), developed by Qilu Pharmaceutical Co., Ltd. were published online in the academic journalFrontiers in Immunology (2022 Impact Factor: 7.3). The title of the paper is "A first-i...

2023-11-06 18:54 1574

Novogene AMEA adopts Olink® Explore HT platform

SINGAPORE, Nov. 6, 2023 /PRNewswire/ -- Novogene Asia Pacific Middle East and Africa (AMEA), a leading provider of genomic services and solutions is pleased to announce the adoption of the Olink® Explore HT platform. The addition of Olink Explore HT enhances Novogene AMEA's capabilities and qual...

2023-11-06 18:00 1794
1 ... 71727374757677 ... 397

Week's Top Stories